Ads
related to: when was zepbound approved- Out-of-Pocket Option
Learn About Savings on Zepbound®
Regardless of Insurance Status.
- How Zepbound® Works
How Zepbound® Works & MOA
Learn More About Zepbound's MOA.
- Safety Information
Learn About The Adverse Reactions
That May Occur.
- Getting Patients Started
Get Support & Tips For
Patients To Start on Zepbound®.
- Clinical Data
Learn About Efficacy
And Safety Clinical Data.
- Official Patient Site
Learn About Treatment Options
On the Official Patient Site.
- Out-of-Pocket Option
Search results
Results From The WOW.Com Content Network
By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted ...
Tirzepatide was approved for medical use in the European Union in September 2022. [11] [49] In December 2024, the FDA approved tirzepatide (Zepbound) as the first medication to be used in the treatment of moderate to severe obstructive sleep apnea.
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
The approval is the second indication for Zepbound, which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.
Zepbound is the first medication approved to treat patients with obstructive sleep apnea, said Sally Seymour, the FDA's director of the division of pulmonology, allergy and critical care. The FDA ...
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, although it is not a cure and requires weight loss to be maintained over time.
Ad
related to: when was zepbound approved